Company intelligence / Profile preview

Endocrine Research Solutions

Roswell, Georgia, United Statesersatl.com ↗

Ownership: Private
Development stage: Other

Overview

Endocrine Research Solutions is an independent clinical research facility specializing in conducting FDA and IRB-monitored clinical trials in endocrinology. The site has over three decades of experience under Principal Investigator Dr. John “Chip” Reed. It provides access to investigational therapies for patients with endocrine/metabolic diseases such as diabetes, cholesterol disorders, diabetic neuropathy, and thyroid conditions. No proprietary drug development or internal pipeline exists.

Therapeutic areas: EndocrinologyCardiovascular
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Beyond the preview

Go deeper on Endocrine Research Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endocrine Research Solutions.

Explore the full profile